Navigation Links
Cephalon Reports Record Earnings and Raises 2010 Guidance
Date:10/28/2010

,193$
,588,610Other revenues

9,91614,18944,29528,583716,993549,4122,040,4881,617,193COSTS AND EXPENSES:Cost of sales

151,93990,456427,721293,633Research and development

110,96699,157317,604304,266Selling, general and administrative

226,791194,068689,900618,314Change in fair value of contingent consideration

5,247-6,314-Restructuring charges

2,3131,0627,6383,944Acquired in-process research and development

-6,000-46,118497,256390,7431,449,1771,266,275INCOME FROM OPERATIONS

219,737158,669591,311350,918OTHER INCOME (EXPENSE):Interest income

9081,8214,1383,455Interest expense

(24,989)(26,495)(78,895)(63,213)Other income (expense), net

(2,846)3,775(19,449)42,418(26,927)(20,899)(94,206)(17,340)INCOME BEFORE INCOME TAXES

192,810137,770497,105333,578INCOME TAX EXPENSE

61,26242,673172,827122,659NET INCOME

131,54895,097324,278210,919NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST

9527,6257,85135,150NET INCOME ATTRIBUTABLE TO CEPHALON, INC.

$
32,500$
2,722$
332,129$
246,069BASIC INCOME PER COMMON SHARE ATTRIBUTABLE TO CEPHALON, INC.

$
.76$
.38$
4.42$
3.44DILUTED INCOME PER COMMON SHARE ATTRIBUTABLE TO CEPHALON, INC.

$
.66$
.31$
4.11$
3.17WEIGHTED AVERAGE NUMBER OF COMMONSHARES OUTSTANDING ATTRIBUTABLE TO CEPHALON, INC.

75,20174,64775,12871,541WEIGHTED AVERAGE NUMBER OF COMMONSHARES OUTSTANDING-ASSUMING DILUTIONATTRIBUTABLE TO CEPHALON, INC.

79,77378,43180,76177,552CEPHALON, INC. AND SUBSIDIARIESReconciliation of GAAP Net Income to Adjusted Net Income Attributable to Cephalon, Inc.(Unaudited)Three Months EndedSeptember 30,20102009GAAP NET INCOME ATTRIBUTABLE TO CEPHALON, INC.

$
32,500$
2,722Cost of sales adjustments

41,050

(1)

21,968

(1)Research and development adjustments

2,014

(2)

1,318

(2)Selling, general and administrative adjust
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
3. Cephalon Completes Acquisition of Arana Therapeutics
4. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Cephalons New Product Launches Pace Record 2008 Sales
9. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
10. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Auckland, New Zealand (PRWEB) May 16, 2013 ... Zealand, was invited to speak to doctors in China about ... across Australia and NZ, this was her first trip to ... , Dr. Hart visited Guangzhou and Fuzhou, home to 12 ... treatments in China is very high at this point in ...
(Date:5/16/2013)... Mass. (PRWEB) May 16, 2013 Cambridge ... Summit from August 19-23, 2013 at the Renaissance Waterfront ... the Summit provide a close-up look at the current ... and ensuring bottom-line quality. Leaders in the field ... ways to produce biopharmaceuticals with greater specificity and efficiency. ...
(Date:5/16/2013)... Ore. , May 16, 2013  HealthSparq, ... many of the nation,s largest regional health plans, ... America,s Health Insurance Plans (AHIP) Institute 2013 conference ... highlight survey results showing how health insurance companies ... for the consumer and marketplace demands for increased ...
(Date:5/16/2013)... HAYWARD, Calif. , May 16, 2013 ... University, Beijing , and the ... www.magceutics.com ) have demonstrated a novel therapy for reversing ... brain magnesium levels, they find significant cognitive improvement in ... to demonstrate a mechanism for reversing cognitive decline for ...
Breaking Biology Technology:The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3
... ... ... ... ...
... ... production, Zap-Hybridoma improves target antibody purity and hybridoma productivity. , ... Fort Collins, CO (PRWEB) ... hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity and ...
... ... announced today that Michelle Flewell, the company’s Vice President of eLearning ... to serve on the Certificate Accreditation Program Advisory Council. Flewell will ... with developing policies and procedures for ICE accreditation of assessment-based certificate ...
Cached Biology Technology:VIVUS to Present at Two Upcoming Investor Conferences 2VIVUS to Present at Two Upcoming Investor Conferences 3InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma 2InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma 3BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council 2BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council 3
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... 95th Annual Meeting in San Francisco, CA from ... promote the entry of students, postdoctorates and scientists ... basic science community and to encourage the participation ... Meeting. , Awards are given to poster/platform presenters ...
(Date:5/16/2013)... For decades, scientists have used ancient shorelines to predict the ... Markings of a high shoreline from three million years ago, ... period were thought to be evidence of a high ... This assumption has led many scientists to think that if ... they may do just the same in our modern, progressively ...
(Date:5/16/2013)... the cellular layer lining the body,s blood vessels, ... nanometers in thickness, this super-tenuous structure routinely withstands ... to create a unique and highly dynamic barrier ... from the body,s circulatory system. , It,s also ... be physically breached to enable immune cells ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... just 9.8 kilobases, the HIV genome pales in comparison ... primate targets. The compact retrovirus encodes just 14 proteins, ... virulence. As a retrovirus, HIV uses the host’s cellular ... RNA genome into DNA and infiltrate human chromosomal DNA. ...
... high-tech microscope will be brought to the marketplace, ... organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial ... announced today that it has signed a licensing ... a new technology called SPIM (Selective Plane Illumination ...
... a pretty good handle on how to teach human cells ... from the mouth's lining to form bone. , But in ... the jaw bone of a person undergoing radiation therapy for ... mouth as well as compensating for the damage of radiation. ...
Cached Biology News:Novel Enzyme Shows Potential As An Anti-HIV Target 2Novel Enzyme Shows Potential As An Anti-HIV Target 3The transparent organism: EMBLEM and Carl Zeiss give labs a unique look at life 2U-M scientist to talk about tissue engineering at AAAS 2